drugset / Trial / NCT01269203

Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients

NCT01269203

RandomizedSingle-groupTriple-blindTreatment

Summary

The goal of this clinical research study is to learn if curcumin can reduce the symptoms reported by patients with multiple myeloma (MM) who receive treatment with lenalidomide.

Timeline

Start
2012-10
Primary completion
2015-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Curcumin Small molecule 1000 mg Oral

Indications